Sustained clinical responses to tyrosine kinase inhibitor sunitinib in thyroid carcinoma

Anti-Cancer Drugs ◽

10.1097/cad.0b013e3282fc6cf7 ◽

2008 ◽

Vol 19 (5) ◽

pp. 547-552 ◽

Author(s):

Sarah-Jane Dawson ◽

Nelly Marmy Conus ◽

Guy C. Toner ◽

Jeanette M. Raleigh ◽

Rodney J. Hicks ◽

...

Keyword(s):

Thyroid Carcinoma ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Kinase Inhibitor ◽

Clinical Responses

Download Full-text

Effects of PTK787/ZK222584, a Tyrosine Kinase Inhibitor, on the Growth of a Poorly Differentiated Thyroid Carcinoma: An Animal Study

Endocrinology ◽

10.1210/en.2003-1228 ◽

2004 ◽

Vol 145 (3) ◽

pp. 1031-1038 ◽

Author(s):

Johann Schoenberger ◽

Daniela Grimm ◽

Peter Kossmehl ◽

Manfred Infanger ◽

Ekkehard Kurth ◽

...

Keyword(s):

Thyroid Carcinoma ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Animal Study ◽

Kinase Inhibitor ◽

Differentiated Thyroid Carcinoma ◽

Poorly Differentiated Thyroid Carcinoma ◽

Poorly Differentiated

Download Full-text

Treatment outcome with a selective RET tyrosine kinase inhibitor selpercatinib in children with multiple endocrine neoplasia type 2 and advanced medullary thyroid carcinoma

European Journal of Cancer ◽

10.1016/j.ejca.2021.09.012 ◽

2021 ◽

Vol 158 ◽

pp. 38-46

Author(s):

Ananth Shankar ◽

Tom Kurzawinski ◽

Emma Ross ◽

Sara Stoneham ◽

Tim Beale ◽

...

Keyword(s):

Treatment Outcome ◽

Thyroid Carcinoma ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Multiple Endocrine Neoplasia ◽

Kinase Inhibitor ◽

Multiple Endocrine Neoplasia Type ◽

Medullary Thyroid ◽

Endocrine Neoplasia

Download Full-text

The tyrosine kinase inhibitor ZD6474 blocks proliferation of RET mutant medullary thyroid carcinoma cells

Endocrine Related Cancer ◽

10.1677/erc-09-0292 ◽

2010 ◽

Vol 18 (1) ◽

pp. 1-11 ◽

Author(s):

D. Vitagliano ◽

V. De Falco ◽

A. Tamburrino ◽

S. Coluzzi ◽

G. Troncone ◽

...

Keyword(s):

Thyroid Carcinoma ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Medullary Thyroid Carcinoma ◽

Kinase Inhibitor ◽

Carcinoma Cells ◽

Medullary Thyroid

Download Full-text

Faculty Opinions recommendation of The tyrosine kinase inhibitor ZD6474 blocks proliferation of RET mutant medullary thyroid carcinoma cells.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.7149958.7379058 ◽

2010 ◽

Author(s):

Gilbert Cote

Keyword(s):

Thyroid Carcinoma ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Medullary Thyroid Carcinoma ◽

Kinase Inhibitor ◽

Carcinoma Cells ◽

Medullary Thyroid

Download Full-text

Both Antiangiogenesis- and Angiogenesis-Independent Effects Are Responsible for Hepatocellular Carcinoma Growth Arrest by Tyrosine kinase Inhibitor PTK787/ZK222584

Yearbook of Oncology ◽

10.1016/s1040-1741(08)70211-2 ◽

2006 ◽

Vol 2006 ◽

pp. 309-310

Author(s):

P.J. Loehrer

Keyword(s):

Hepatocellular Carcinoma ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Kinase Inhibitor ◽

Growth Arrest ◽

Independent Effects

Download Full-text

Dual-agent molecular targeting of growth factor receptors in hepatocellular cancer: Combining anti-EGFR antibody with an EGFR tyrosine kinase inhibitor

Zeitschrift für Gastroenterologie ◽

10.1055/s-2005-920152 ◽

2005 ◽

Vol 43 (05) ◽

Author(s):

A Hüther ◽

M Höpfner ◽

D Schuppan ◽

H Scherübl

Keyword(s):

Growth Factor ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Kinase Inhibitor ◽

Hepatocellular Cancer ◽

Growth Factor Receptors ◽

Molecular Targeting ◽

Egfr Tyrosine Kinase Inhibitor ◽

Egfr Tyrosine Kinase ◽

Download Full-text

Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor

10.32388/jfobd7 ◽

2020 ◽

Author(s):

Keyword(s):

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Receptor Tyrosine Kinase Inhibitor ◽

Epidermal Growth

Download Full-text

A Case of Metastatic Renal Cell Carcinoma to the Maxillary Sinus Treated with Tyrosine Kinase Inhibitor

Korean Journal of Otorhinolaryngology - Head and Neck Surgery ◽

10.3342/kjorl-hns.2012.55.11.717 ◽

2012 ◽

Vol 55 (11) ◽

pp. 717 ◽

Author(s):

Young Hyo Kim ◽

Jae Eun Kim ◽

Sungmin Park ◽

Tae Young Jang

Keyword(s):

Renal Cell Carcinoma ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Cell Carcinoma ◽

Maxillary Sinus ◽

Metastatic Renal Cell Carcinoma ◽

Kinase Inhibitor

Download Full-text

Tyrosine kinase inhibitor (TKI) treatment outcome of stage IV-C thyroid differentiated cancer (analyzed by lesion evaluation)

Endocrine Abstracts ◽

10.1530/endoabs.56.p1139 ◽

2018 ◽

Author(s):

Hiroyuki Iwasaki ◽

Haruhiko Yamazaki ◽

Nobuyasu Suganuma ◽

Yuko Sugawara ◽

Naoki Gotoh ◽

...

Keyword(s):

Treatment Outcome ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Kinase Inhibitor ◽

Stage Iv ◽

Download Full-text

17 / An Observational Study of Survival in Patients With Chronic-Phase Chronic Myeloid Leukemia (CML-CP) After 1, 3, and 5 Years of Tyrosine Kinase Inhibitor (TKI) Therapy (SIMPLICITY)

10.26226/morressier.5b3b802cb1b87b000eced8f4 ◽

2018 ◽

Author(s):

Mauro Michael J.

Keyword(s):

Chronic Myeloid Leukemia ◽

Observational Study ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Myeloid Leukemia ◽

Kinase Inhibitor ◽

Download Full-text